HPS Pharmacies wish to give notice that Viatris is experiencing some supply issues for midazolam as follows:
Midazolam Viatris
Midazolam 5 mg/5 mL
ARTG 160206
Supplies of this product are currently limited, although warehouses do still have stock available.
To address the supply issues, the sponsor has made alternative supply arrangements under Section 14 and 14A of the Therapeutic Goods Act 1989. This has allowed Viatris to supply an equivalent product that is registered in New Zealand. This approval is valid until November 2025. However, Viatris anticipates that this replacement stock will only be required between mid-January and mid-March 2025.
The formulation of the NZ registered product is identical to the Australian-registered product. However, the NZ product has additional routes of administration listed on the packaging that are not registered in Australia. The NZ product will be supplied with an over label to include Australian registration details.
The Australian Product Information should be referred to for further information, including administration advice. If patients require further information, they should be directed to the Australian Consumer Medicines Information leaflet.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Viatris on 1800 274 276 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates